489 related articles for article (PubMed ID: 25552476)
21. Phytochemical profile and therapeutic potential of Viscum album L.
Nazaruk J; Orlikowski P
Nat Prod Res; 2016; 30(4):373-85. PubMed ID: 25813519
[TBL] [Abstract][Full Text] [Related]
22. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
[TBL] [Abstract][Full Text] [Related]
23. Mistletoe in conventional oncological practice: exemplary cases.
Legnani W
Integr Cancer Ther; 2008 Sep; 7(3):162-71. PubMed ID: 18956494
[TBL] [Abstract][Full Text] [Related]
24. Safety of Combined Targeted and Helixor
Schad F; Thronicke A
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767928
[TBL] [Abstract][Full Text] [Related]
25. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer.
Thronicke A; Steele ML; Grah C; Matthes B; Schad F
BMC Complement Altern Med; 2017 Dec; 17(1):534. PubMed ID: 29237435
[TBL] [Abstract][Full Text] [Related]
26. [Mistletoe in the treatment of cancer patients].
Rostock M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):535-540. PubMed ID: 32211937
[TBL] [Abstract][Full Text] [Related]
27. Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series.
Zuzak TJ; Wasmuth A; Bernitzki S; Schwermer M; Längler A
Complement Ther Med; 2018 Oct; 40():198-202. PubMed ID: 30219449
[TBL] [Abstract][Full Text] [Related]
28. [Viscum album L. (Iscador) in the cat: tolerance, adverse reactions and indications].
Glardon ; Pache ; Magnenat ; Pin ; Parvis
Schweiz Arch Tierheilkd; 2014 Aug; 156(8):381-8. PubMed ID: 25082635
[TBL] [Abstract][Full Text] [Related]
29. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
Pelzer F; Tröger W; Nat DR
J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
[TBL] [Abstract][Full Text] [Related]
30. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
von Schoen-Angerer T; Wilkens J; Kienle GS; Kiene H; Vagedes J
Perm J; 2015; 19(4):76-83. PubMed ID: 26517439
[TBL] [Abstract][Full Text] [Related]
31. Use and Safety of Viscum album L Applications in Cancer Patients With Preexisting Autoimmune Diseases: Findings From the Network Oncology Study.
Oei SL; Thronicke A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2019; 18():1534735419832367. PubMed ID: 30808274
[TBL] [Abstract][Full Text] [Related]
32. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
[TBL] [Abstract][Full Text] [Related]
33. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
Stoss M; van Wely M; Musielsky H; Gorter RW
Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
[TBL] [Abstract][Full Text] [Related]
34. Viscum Album in the Treatment of a Girl With Refractory Childhood Absence Epilepsy.
von Schoen-Angerer T; Madeleyn R; Kienle G; Kiene H; Vagedes J
J Child Neurol; 2015 Jul; 30(8):1048-52. PubMed ID: 25038133
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
[TBL] [Abstract][Full Text] [Related]
36. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report.
von Schoen-Angerer T; Goyert A; Vagedes J; Kiene H; Merckens H; Kienle GS
J Gastrointestin Liver Dis; 2014 Dec; 23(4):449-52. PubMed ID: 25532007
[TBL] [Abstract][Full Text] [Related]
37. Anaphylactic reactions after therapeutic injection of mistletoe (Viscum album L.).
Hutt N; Kopferschmitt-Kubler M; Cabalion J; Purohit A; Alt M; Pauli G
Allergol Immunopathol (Madr); 2001; 29(5):201-3. PubMed ID: 11720654
[TBL] [Abstract][Full Text] [Related]
38. Synergistic Antitumour Properties of
Stammer RM; Kleinsimon S; Rolff J; Jäger S; Eggert A; Seifert G; Delebinski CI
J Immunol Res; 2017; 2017():4874280. PubMed ID: 28791312
[TBL] [Abstract][Full Text] [Related]
39. Viscum album L. Therapy in Oncology: An Update on Current Evidence.
Thronicke A; Schad F; Debus M; Grabowski J; Soldner G
Complement Med Res; 2022; 29(4):362-368. PubMed ID: 35325897
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.
Lee YG; Jung I; Koo DH; Kang DY; Oh TY; Oh S; Lee SS
Support Care Cancer; 2019 May; 27(5):1945-1949. PubMed ID: 30218188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
